ChemoCentryx, Inc. Operating Lease, Variable Lease Income
ChemoCentryx, Inc. reported Operating Lease, Variable Lease Income of $0 for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeaseVariableLeaseIncome · last filed 2022-08-08
- ChemoCentryx, Inc. operating lease, variable lease income for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- ChemoCentryx, Inc. operating lease, variable lease income for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- ChemoCentryx, Inc. operating lease, variable lease income for the quarter ending 2021-12-31 was $900.00K, a 88.89% decline year-over-year.
- ChemoCentryx, Inc. operating lease, variable lease income for the quarter ending 2021-09-30 was $2.30M, a 475.00% increase year-over-year.
- ChemoCentryx, Inc. operating lease, variable lease income for fiscal 2021 was $10.90M, a 17.20% increase from fiscal 2020.
- ChemoCentryx, Inc. operating lease, variable lease income for fiscal 2020 was $9.30M.
| Period end | Operating Lease, Variable Lease Income 3 month | Operating Lease, Variable Lease Income 6 month | Operating Lease, Variable Lease Income 9 month | Operating Lease, Variable Lease Income 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $900.00K derived: sum of 3 quarters · filed 2022-08-08 | $3.20M derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $900.00K derived: sum of 2 quarters · filed 2022-05-10 | $3.20M derived: sum of 3 quarters · filed 2022-05-10 | $5.00M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.20M derived: sum of 2 quarters · filed 2022-03-01 | $5.00M derived: sum of 3 quarters · filed 2022-08-08 | $10.90M 10-K · filed 2022-03-01 |
| 2021-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $4.10M derived: sum of 2 quarters · filed 2022-08-08 | $10.00M 10-Q · filed 2021-11-09 | $18.10M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $7.70M 10-Q · filed 2022-08-08 | $15.80M derived: sum of 3 quarters · filed 2022-08-08 | $16.20M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $5.90M 10-Q · filed 2022-05-10 | $14.00M derived: sum of 2 quarters · filed 2022-05-10 | $14.40M derived: sum of 3 quarters · filed 2022-05-10 | $14.80M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $8.50M derived: sum of 2 quarters · filed 2022-03-01 | $8.90M derived: sum of 3 quarters · filed 2022-03-01 | $9.30M 10-K · filed 2022-03-01 |
| 2020-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $800.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.20M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $800.00K 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $400.00K 10-Q · filed 2021-05-03 |